Career history of Micah Zajic
Former positions of Micah Zajic
| Companies | Position | Start | End |
|---|---|---|---|
| LEXEO THERAPEUTICS, INC. | Director of Finance/CFO | 31/12/2022 | 30/06/2023 |
| Corporate Officer/Principal | 30/06/2023 | 30/12/2023 | |
| SQZ BIOTECHNOLOGIES COMPANY | Director of Finance/CFO | 10/07/2022 | 30/12/2022 |
| Corporate Officer/Principal | 15/09/2020 | 10/07/2022 | |
MeiraGTx Ltd.
 MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 31/03/2017 | 31/08/2020 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/03/2014 | 31/03/2017 |
Training of Micah Zajic
| Georgetown University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Director of Finance/CFO | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| LEXEO THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Micah Zajic
- Experience